| Outcome Measures: |
Primary: Difference in A1C between groups at 6 months, 6 months | Secondary: Difference in A1C between groups at 3 months, 3 months|Difference in self-monitored blood glucose averages between groups, Outside of A1C, the investigators will also be comparing self-monitored blood glucose averages within each group and comparing them to one another., 6 months|Difference in incidence of hypoglycemia between each group, * Mild = symptoms consistent with hypoglycemia during which the subject was able to self-treat and was associated with blood glucose \< 70mg/dL * Severe = symptoms consistent with hypoglycemia during which the subject required the assistance of another person and was associated with either a glucose level \< 56 mg/dL or prompt recovery after oral carbohydrate, intravenous glucose, or glucagon * Nocturnal hypoglycemia = hypoglycemia as described above occurring after the subject goes to bed and before the measurement of glucose, eating breakfast, or administration of any glucose-lowering agent in the morning, 6 months|Difference in units of basal insulin used per day between groups, 6 months|Difference in total units of insulin per day between groups, 6 months|Difference in percent of patients who require initiation/titration of prandial insulin between each group, 6 months|Difference in rate of mortality in each group during study period, 6 months|Difference in morbidity between each group during study period, Morbidity defined as glycemia-related hospitalizations, ER visits, immediate care clinic visits (hypoglycemia, hyperglycemia, diabetic ketoacidosis, hyperosmolar hyperglycemic nonketotic syndrome, hospitalizations diagnosed as related to diabetes with diagnosis code), 6 months|Compare cost of insulin therapy over study period at study completion, Costs will be calculated as direct patient cost and total cost of medication., 6 months|Differences in change in weight during study period between groups, Weight change in each patient will be calculated using weight at study initiation and completion, 6 months|Difference in number of visits with clinical pharmacist, 6 months
|
